Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Classe

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
The Breast Journal|March 14, 2020
Evaluation of predictor risk factors and calculation of a margin index for ipsilateral invasive recurrence following treatment of DCIS: A 15-year observational studyMarion Brooks, Jean-Marc Classe, Romuald Wernert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 24, 2022
CHRONO: randomized trial of the CHROnology of surgery after Neoadjuvant chemotherapy for Ovarian cancerJean-Marc Classe, Gwennael Ferron, Lobna Ouldamer, et al.
Annals of Surgical Oncology|July 11, 2013
Margin width should not still enforce a systematic surgical re-excision in the conservative treatment of early breast infiltrative ductal carcinomaIsabelle Jaffré, Loic Campion, Magali Dejode, et al.
The Breast Journal|March 5, 2008
Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomyChristine Tunon-de-Lara, Sylvia Giard, Max Buttarelli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patientsBarnabe Bouvarel, Oliver Colomban, Jean-Sebastien Frenel, et al.
JAMA Surgery|April 21, 2021
Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease: A Systematic Review and Meta-analysisSanaz Samiei, Janine M Simons, Sanne M E Engelen, et al.
Bulletin Du Cancer|March 11, 2023
[State of results of HIPEC for epithelial ovarian cancer in the primary treatment or for relapse]Jean-Marc Classe, Jean-Sébastien Frenel, Dominique Berton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 19, 2024
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patientsBarnabe Bouvarel, Oliver Colomban, Jean-Sebastien Frenel, et al.
Cancer|February 26, 2004
Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective studyJean-Marc Classe, Delphine Loussouarn, Loïc Campion, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancerJulia Bonastre, Julie Chevalier, Dominique Elias, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
The Breast Journal|March 14, 2020
Evaluation of predictor risk factors and calculation of a margin index for ipsilateral invasive recurrence following treatment of DCIS: A 15-year observational studyMarion Brooks, Jean-Marc Classe, Romuald Wernert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 24, 2022
CHRONO: randomized trial of the CHROnology of surgery after Neoadjuvant chemotherapy for Ovarian cancerJean-Marc Classe, Gwennael Ferron, Lobna Ouldamer, et al.
Annals of Surgical Oncology|July 11, 2013
Margin width should not still enforce a systematic surgical re-excision in the conservative treatment of early breast infiltrative ductal carcinomaIsabelle Jaffré, Loic Campion, Magali Dejode, et al.
The Breast Journal|March 5, 2008
Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomyChristine Tunon-de-Lara, Sylvia Giard, Max Buttarelli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patientsBarnabe Bouvarel, Oliver Colomban, Jean-Sebastien Frenel, et al.
JAMA Surgery|April 21, 2021
Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease: A Systematic Review and Meta-analysisSanaz Samiei, Janine M Simons, Sanne M E Engelen, et al.
Bulletin Du Cancer|March 11, 2023
[State of results of HIPEC for epithelial ovarian cancer in the primary treatment or for relapse]Jean-Marc Classe, Jean-Sébastien Frenel, Dominique Berton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 19, 2024
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patientsBarnabe Bouvarel, Oliver Colomban, Jean-Sebastien Frenel, et al.
Cancer|February 26, 2004
Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective studyJean-Marc Classe, Delphine Loussouarn, Loïc Campion, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancerJulia Bonastre, Julie Chevalier, Dominique Elias, et al.
Pageof 11